Induction of nuclear translocation of constitutive androstane receptor by peroxisome proliferator-activated receptor α synthetic ligands in mouse liver

被引:32
|
作者
Guo, Dongsheng
Sarkar, Joy
Suino-Powell, Kelly
Xu, Yong
Matsumoto, Kojiro
Jia, Yuzhi
Yu, Songtao
Khare, Sonal
Haldar, Kasturi
Rao, M. Sambasiva
Foreman, Jennifer E.
Monga, Satdarshan P. S.
Peters, Jeffrey M.
Xu, H. Eric
Reddy, Janardan K.
机构
[1] Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL 60611 USA
[2] Van Andel Res Inst, Lab Struct Sci, Grand Rapids, MI 49503 USA
[3] Penn State Univ, Dept Vet & Biomed Sci, Ctr Mol Toxicol & Carcinogenesis, University Pk, PA 16802 USA
[4] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15261 USA
关键词
D O I
10.1074/jbc.M707183200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Peroxisome proliferators activate nuclear receptor peroxisome proliferator-activated receptor alpha ( PPAR alpha) and enhance the transcription of several genes in liver. We report here that synthetic PPAR alpha ligands Wy-14,643, ciprofibrate, clofibrate, and others induce the nuclear translocation of constitutive androstane receptor (CAR) in mouse liver cells in vivo. Adeno-viral-enhanced green fluorescent protein-CAR expression demonstrated that PPAR alpha synthetic ligands drive CAR into the hepatocyte nucleus in a PPAR alpha- and PPAR beta-independent manner. This translocation is dependent on the transcription coactivator PPAR-binding protein but independent of coactivators PRIP and SRC-1. PPAR alpha ligand-induced nuclear translocation of CAR is not associated with induction of Cyp2b10 mRNA in mouse liver. PPAR alpha ligands interfered with coactivator recruitment to the CAR ligand binding domain and reduced the constitutive transactivation of CAR. Both Wy-14,643 and ciprofibrate occupied the ligand binding pocket of CAR and adapted a binding mode similar to that of the CAR inverse agonist androstenol. These observations, therefore, provide information for the first time to indicate that PPAR alpha ligands not only serve as PPAR alpha agonists but possibly act as CAR antagonists.
引用
收藏
页码:36766 / 36776
页数:11
相关论文
共 50 条
  • [1] Peroxisome proliferator-activated receptor (PPAR)-binding protein (PBP) but not PPAR-interacting protein (PRIP) is required for nuclear translocation of constitutive androstane receptor in mouse liver
    Guo, Dongsheng
    Sarkar, Joy
    Ahmed, Mohamed R.
    Viswakarma, Navin
    Jia, Yuzhi
    Yu, Songtao
    Rao, M. Sambasiva
    Reddy, Janardan K.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 347 (02) : 485 - 495
  • [2] Ligands for the Nuclear Peroxisome Proliferator-Activated Receptor Gamma
    Sauer, Sascha
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2015, 36 (10) : 688 - 704
  • [3] Plasticizers May Activate Human Hepatic Peroxisome Proliferator-Activated Receptor α Less Than That of a Mouse but May Activate Constitutive Androstane Receptor in Liver
    Ito, Yuki
    Nakamura, Toshiki
    Yanagiba, Yukie
    Ramdhan, Doni Hikmat
    Yamagishi, Nozomi
    Naito, Hisao
    Kamijima, Michihiro
    Gonzalez, Frank J.
    Nakajima, Tamie
    PPAR RESEARCH, 2012, 2012
  • [4] Transcription coactivator PRIP, the peroxisome proliferator-activated receptor (PPAR)-interacting protein, is redundant for the function of nuclear receptors PPARα and CAR, the constitutive androstane receptor, in mouse liver
    Sarkar, Joy
    Chao, Q.
    Guo, Dongsheng
    Ahmed, Mohamed R.
    Jia, Yuzhi
    Usuda, Nobuteru
    Viswakarma, Navin
    Rao, M. Sambasiva
    Reddy, Janardan K.
    GENE EXPRESSION, 2007, 13 (4-5): : 255 - 269
  • [5] Peroxisome proliferator-activated receptor ligands in atherosclerosis
    Viles-Gonzalez, JF
    Choi, BG
    Fuster, V
    Badimon, JJ
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2004, 13 (11) : 1393 - 1403
  • [6] Antiepileptic Drug-Activated Constitutive Androstane Receptor Inhibits Peroxisome Proliferator-Activated Receptor α and Peroxisome Proliferator-Activated Receptor γ Coactivator 1α-Dependent Gene Expression to Increase Blood Triglyceride Levels
    Shizu, Ryota
    Otsuka, Yuta
    Ezaki, Kanako
    Ishii, Chizuru
    Arakawa, Shingo
    Amaike, Yuto
    Abe, Taiki
    Hosaka, Takuomi
    Sasaki, Takamitsu
    Kanno, Yuichiro
    Miyata, Masaaki
    Yamazoe, Yasushi
    Yoshinari, Kouichi
    MOLECULAR PHARMACOLOGY, 2020, 98 (05) : 634 - 647
  • [7] The Emerging Role of Constitutive Androstane Receptor and Its Cross talk with Liver X Receptors and Peroxisome Proliferator-Activated Receptor A in Lipid Metabolism
    Xiao, Lei
    Wang, Jing
    Jiang, Mengxi
    Xie, Wen
    Zhai, Yonggong
    OBESITY, 2013, 91 : 243 - 258
  • [8] Constitutive active/androstane receptor, peroxisome proliferator-activated receptor α, and cytotoxicity are involved in oxadiazon-induced liver tumor development in mice
    Kuwata, Kazunori
    Inoue, Kaoru
    Ichimura, Ryohei
    Takahashi, Miwa
    Kodama, Yukio
    Yoshida, Midori
    FOOD AND CHEMICAL TOXICOLOGY, 2016, 88 : 75 - 86
  • [9] Identification of Modulators of the Nuclear Receptor Peroxisome Proliferator-Activated Receptor α (PPARα) in a Mouse Liver Gene Expression Compendium
    Oshida, Keiyu
    Vasani, Naresh
    Thomas, Russell S.
    Applegate, Dawn
    Rosen, Mitch
    Abbott, Barbara
    Lau, Christopher
    Guo, Grace
    Aleksunes, Lauren M.
    Klaassen, Curtis
    Corton, J. Christopher
    PLOS ONE, 2015, 10 (02):
  • [10] Constitutive Androstane Receptor and Peroxisome Proliferator-Activated Receptor a Do Not Perform Liquid-Liquid Phase Separation in Cells
    Zhao, Pengfei
    Fan, Shicheng
    Zhou, Yanying
    Huang, Min
    Gao, Yue
    Bi, Huichang
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2024, 390 (01): : 88 - 98